Ascending Single Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HTC-867 Administered Orally to Healthy Subjects.

Trial Profile

Ascending Single Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HTC-867 Administered Orally to Healthy Subjects.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 09 Dec 2009

At a glance

  • Drugs HTC 867 (Primary)
  • Indications Psychotic disorders
  • Focus Adverse reactions
  • Most Recent Events

    • 02 Sep 2009 Planned end date changed from 1 Jun 2009 to 1 Apr 2009 as reported by ClinicalTrials.gov.
    • 02 Sep 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 28 Apr 2009 Additional location identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top